Giant Axonal Neuropathy (GAN) Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Giant Axonal Neuropathy (GAN) Market is segmented By Treatment (Gene Therapy, Enzyme Replacement Therapy, Supportive Care), By Distribution Channel (H....
Competitive overview of Giant Axonal Neuropathy (GAN) Market
The major players operating in the giant axonal neuropathy (GAN) market include Applied Genetic Technologies Corporation (AGTC), Audentes Therapeutics (acquired by Astellas Pharma), Passage Bio, Voyager Therapeutics, and Neuron Biopharma.
Giant Axonal Neuropathy (GAN) Market Leaders
- Applied Genetic Technologies Corporation (AGTC)
- Audentes Therapeutics (acquired by Astellas Pharma)
- Passage Bio
- Voyager Therapeutics
- Neuron Biopharma
*Disclaimer: Major players are listed in no particular order.
Giant Axonal Neuropathy (GAN) Market - Competitive Rivalry, undefined
Giant Axonal Neuropathy (GAN) Market
Market Consolidated
(Dominated by major players)
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
(Highly competitive with lots of players.)
*Source: Coherent Market Insights